DIAPH3 predicts survival of patients with MGMT-methylated glioblastoma.
Chehade G, El Hajj N, Aittaleb M, Alkailani MI, Bejaoui Y, Mahdi A, Aldaalis AAH, Verbiest M, Lelotte J, Ruiz-Reig N, Durá I, Raftopoulos C, Tajeddine N, Tissir F.
Chehade G, et al. Among authors: tissir f.
Front Oncol. 2024 Feb 22;14:1359652. doi: 10.3389/fonc.2024.1359652. eCollection 2024.
Front Oncol. 2024.
PMID: 38454929
Free PMC article.